stockrow
Friday 6 November 2026
Export JBS’s income statement to Excel — free account
JBS N.V.
JBS Consumer Defensive Packaged Foods
JBS N.V.’s revenue for fiscal 2025 (year ended December 2025) was $86.2 billion, up 11.7% from fiscal 2024.
- Revenue
- +13.8%
- EPS
- −120.8%
- Free cash flow
- +238.9%
- Total debt
- +15.1%
Quarter to June 2026, against a year earlier
12.50
0.30
−2.34%
Follow JBS
Alert me
| Dec '25 | Dec '24 | |
|---|---|---|
P/E ratio |
7.75 | 7.56 |
Altman Z-Score |
2.72 | — |
P/S ratio |
0.18 | 0.00 |
Altman Z″-Score (non-manufacturers) |
2.05 | — |
P/FCF ratio |
17.14 | 0.00 |
Beneish M-Score |
(2.28) | — |
P/Operating CF |
7.96 | 8.56 |
P/B ratio |
1.62 | 1.62 |
Price to Tangible BV |
8.35 | 14.41 |
EV/Sales |
0.39 | 0.00 |
EV/EBITDA |
5.13 | 0.00 |
EV/Operating CF |
11.32 | 0.00 |
EV/FCF |
36.92 | 0.00 |
Quick Ratio |
0.86 | 0.87 |
Current Ratio |
1.60 | 1.47 |
Net Debt/EBITDA |
2.75 | 2.28 |
Debt/Assets |
49.83% | 50.94% |
Debt/Equity |
2.36 | 2.55 |
Asset Turnover |
2.01 | 0.00 |
Operating CF/Net income |
1.45 | 2.39 |
Capex/Depreciation |
(0.88) | (0.66) |
Interest Coverage |
1.96 | 1.83 |
| 22.93% | 0.00% | |
| 4.72% | 0.00% | |
ROIC |
9.52% | 11.84% |
Return on Tangible Assets |
9.85% | 10.25% |
Average Days of Receivables |
21.98 | 20.68 |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
8.33% | 9.21% |
Intangible Assets out of Total Assets |
0.17 | 0.18 |
Share Based Compensation of Revenue |
0.03% | 0.02% |
Graham Net Nets |
(1.12) | (1.17) |
Graham Number |
19.31 | 0.00 |
Earnings Yield |
12.90% | 13.23% |
Free Cash Flow Yield |
5.83% | 0.00% |
Revenue per Share |
80.66 | 72.23 |
Operating CF per Share |
2.74 | 3.96 |
Capex per Share |
(1.90) | (1.35) |
Free Cash Flow per Share |
0.84 | 2.61 |
Cash per Share |
4.42 | 5.38 |
Shareholders Equity per Share |
8.91 | 7.61 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
8.91 | 7.61 |
Free Cash Flow |
898.76 | 2,785.88 |
Working Capital |
6,896.39 | 5,463.95 |
Capital Expenditures |
(2,033.19) | (1,443.67) |
Net Current Asset Value |
(17,195.50) | (15,429.99) |
EV/EBIT |
7.98 | 0.00 |
Capex to Sales |
0.02 | 0.02 |
Price to Operating Income |
3.70 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
0.17 | 0.19 |
Cash ROIC |
2.45% | 8.05% |
Accounts Receivable Turnover |
18.02 | 0.00 |
Accounts Payable Turnover |
12.84 | 0.00 |
Inventory Turnover |
10.29 | 0.00 |
Average Days of Payables |
30.21 | 30.41 |
Days of Inventory on Hand |
38.67 | 36.86 |
Average Receivables |
4,781.93 | — |
Average Payables |
5,831.81 | — |
Average Inventory |
7,279.07 | — |
Average Assets |
42,920.93 | — |
Average Common Equity |
8,828.58 | — |
Columns are period end dates · fundamentals updated 26 Oct 2026